medigraphic.com
Federación Mexicana de Ginecología y Obstetricia, A.C.

2021, Number 08

<< Back Next >>

Ginecol Obstet Mex 2021; 89 (08)

Uterine artery Doppler in chronic hypertensive pregnant women as a predictor of preeclampsia with criteria of over-aggregated severity and need for intensive care

Bohórquez-Camargo DC, Guerrero-Solano AM, Becerra-Mojica CH, Díaz-Martínez LA

Language: Spanish
References: 22
Page: 611-621
PDF size: 194.22 Kb.


ABSTRACT

Objective: To evaluate the usefulness of Doppler ultrasound of the uterine arteries performed between 18 and 23 weeks in chronically hypertensive pregnant women as a predictor of preeclampsia with criteria of severity or need for intensive care.
Materials and Methods: Prospective cohort study of diagnostic technology evaluation carried out in an institution in eastern Colombia with pregnant patients, chronic hypertensive, attended between April 2013 and September 2020. followed until the end of pregnancy, in whom Doppler ultrasound of the uterine arteries was performed between 18 to 23 weeks of pregnancy and subsequent evaluation of three outcomes: occurrence of preeclampsia, preeclampsia with severity criteria or need for intensive care. Markers of diagnostic performance and concordance beyond chance were estimated.
Results: 104 patients with age limits of 18 and 44 years were captured. Of the Doppler ultrasound scans performed, 31 (29.8%) were positive. After these, 73 (70.1%) patients had preeclampsia; 27 (37.0%) reached term, 17 (23.2%) terminated between 34.0 and 36.6 weeks, 21 (28.8%) between 24.0 and 33.6 weeks, and 8 (10.9%) before fetal viability. The negative predictive value for intensive care was 97.0%. In patients with positive proteinuria at the time of ultrasound, the sensitivity and positive predictive value was 100.0%. A positive report implied a relative risk of 2.18 (95%CI: 1.59-2.98) for severe preeclampsia and 5.61 (95%CI: 1.32-23.90) for the need for intensive care.
Conclusion: Doppler ultrasound of the uterine arteries in chronically hypertensive pregnant women is predictive of risk of severe preeclampsia and need for intensive care, particularly if they have significant proteinuria at the time of examination.


REFERENCES

  1. Seely EW, Ecker J. Chronic hypertension in pregnancy. Circulation 2014; 129 (11): 1254-61. doi: 10.1161/CIRCULATIONAHA.113.003904.

  2. Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, et al. Global disparities of hypertension prevalence and control: A systematic analysis of population-based studies from 90 countries. Circulation 2016; 134 (6): 441-50. doi: 10.1161/circulationaha.115.018912.

  3. Martínez-Acevedo AM. Resultados maternos y perinatales de las gestantes con hipertensión crónica atendidas en el Hospital Universitario de Santander en quinquenio 2007-2012. 2014. Bucaramanga: Trabajo de grado. http:// tangara.uis.edu.co/biblioweb/tesis/2014/151204.pdf

  4. Atallah A, Lecarpentier E, Goffinet F, Doret-Dion M, Gaucherand P, Tsatsaris V. Aspirin for prevention of preeclampsia. Drugs 2017; 77 (17): 1819-31. doi: 10.1007/s40265-017-0823-0.

  5. Gonzales Medina CA, Alegría Guerrero CR. ¿Es posible predecir la preeclampsia? Rev Peru Ginecol Obstet 2014; 60 (4): 363-72.

  6. Guerrero-Solano AM. Utilidad del Doppler de arterias uterinas en la predicción de PE en mujeres con hipertensión crónica. Trabajo de grado.2017.

  7. Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222. Obstet Gynecol 2020; 135 (6): e237- 60. doi: 10.1097/AOG.0000000000003891.

  8. Chamy P V, Cardemil M F, Betancour M P, Ríos S M, Leighton L V. Riesgo obstétrico y perinatal en embarazadas mayores DE 35 años. Rev Chil Obstet Ginecol 2009; 74 (6): 331-6. doi: 10.4067/s0717-75262009000600003.

  9. Mardones SF. Evolución de la antropometría materna y del peso de nacimiento en Chile, 1987-2000. Rev Chil Nutr 2003; 30 (2). doi: 10.4067/s0717-75182003000200006.

  10. ACOG practice bulletin no. 203: Chronic hypertension in pregnancy: Chronic hypertension in pregnancy. Obstet Gynecol 2019; 133 (1): e26–50. doi: 10.1097/ AOG.0000000000003020.

  11. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Rev Esp Cardiol 2019; 72 (2): 160.e1-160. e78. doi: 10.1016/j.recesp.2018.12.005.

  12. Ananth CV, Peltier MR, Kinzler WL, Smulian JC, Vintzileos AM. Chronic hypertension and risk of placental abruption: is the association modified by ischemic placental disease? Am J Obstet Gynecol 2007; 197 (3): 273.e1-273.e7. doi: 10.1016/j.ajog.2007.05.047.

  13. Mendoza-Cáceres MA, Moreno-Pedraza LC, Becerra-Mojica CH, Díaz-Martínez LA. Desenlaces materno-fetales de los embarazos con trastornos hipertensivos: Un estudio transversal. Rev Chil Obstet Ginecol 2020; 85 (1): 14-23. doi: 10.4067/S0717-75262020000100014.

  14. Sibai BM, Koch MA, Freire S, Pinto e Silva JL, Rudge MVC, Martins-Costa S, et al. The impact of prior preeclampsia on the risk of superimposed preeclampsia and other adverse pregnancy outcomes in patients with chronic hypertension. Am J Obstet Gynecol 2011; 204 (4): 345.e1-6. doi: 10.1016/j.ajog.2010.11.027.

  15. Cairo V, Suárez JA, Escobar A, López RL, Marín Y, Gutiérrez M. Resultados del uso del ácido acetilsalicílico y los suplementos de calcio en la prevención de la preeclampsia. Rev Cuba Obstet Ginecol 2017; 43 (3): 80-95.

  16. Atallah A, Lecarpentier E, Goffinet F, Gaucherand P, DoretDion M, Tsatsaris V. Aspirine et prééclampsie. Presse Med 2019; 48 (1 Pt 1): 34-45. doi: 10.1016 / j.lpm.2018.11.022.

  17. Villa PM, Kajantie E, Räikkönen K, Pesonen A-K, Hämäläinen E, Vainio M, et al. Aspirin in the prevention of preeclampsia in high-risk women: a randomised placebo-controlled PRE- DO Trial and a meta-analysis of randomised trials: PREDO trial - aspirin in the prevention of preeclampsia. BJOG 2013; 120 (1): 64-74. doi: 10.1111 / j.1471-0528.2012.03493.x.

  18. Ortiz Dueñas SE, Ochoa Bustamante JP, Hidalgo Castelo ME, Valenzuela Valencia A. La importancia ultrasonográfica del Doppler de arteria uterina en la enfermedad hipertensiva del embarazo. RECIAMUC 2020; 4 (4): 207-13. doi: 10.26820/reciamuc/4.

  19. Bravo CZ, Reyes SA, Limones M, Gaytán AM. Metanálisis de los factores para detección precoz de hipertensión inducida por el embarazo y protocolos en hipertensión previa. Centro Sur 2020; 4 (1): 1-18. doi: 10.37955/cs.v4i1.30.

  20. Özkara A, Kaya AE, Başbuğ A, Ökten SB, Doğan O, Çağlar M, et al. Proteinuria in preeclampsia: is it important? Ginekol Pol 2018; 89 (5): 256-61. doi: 10.5603 / GP.a2018.0044.

  21. Salgado LF, García Fontalvo KA. Principales marcadores bioquímicos que actúan como predictores de severidad en pacientes con preeclampsia severa en edades entre 18 y 26 años en el Hospital Niño Jesús de Barranquilla, 2014- 2015. Biociencias 2015; 10 (2): 29-36. file:///C:/Users/ nizjo/AppData/Local/Temp/2639-Texto%20del%20art%C 3%ADculo-4058-1-10-20180918.pdf

  22. Garduño García G, Cruz López M de J, Uicab Jiménez DMB, Cruz Gómez LM, Medina Jiménez V, Hernández Pacheco JA, et al. Correlación de los valores de sFlt-1, PlGF y su cociente en preeclampsia con criterios de severidad en una Unidad de Cuidados Intensivos. Medicina Crítica 2019; 33 (6): 311-4.




2020     |     www.medigraphic.com